collected from a clinical trial involving GHB administration to volunteers, were tested; the presence of GHB in these samples was confirmed by gas chromatography-mass spectrometry. This study was reviewed and approved by the University of California Committee on Human Research. Approximate calibrations of the strips were performed in duplicate by spiking drug-free urine with known quantities of GHB standard in methanol (Cerilliant, Austin, TX) and comparing the observed color results with the result concentrations given by the manufacturer. The GHB concentration ranged from 0 to 0.5 mg/mL. Twenty microliters of urine were pipetted onto the reactive pads of the test strips to saturate the pads. The strips were then allowed to develop for 10 min, and the observed dye concentrations were compared to the known color chart. The color readings in duplicates observed were found to be consistent with the color chart provided.
All of the six known-positives yielded positive results in the range of 0-0.05 mg/mL. Six of the 670 clinical samples from the urine toxicology testing showed borderline results with a GHB concentration estimated at 0.01 mg/mL. The remaining 664 patient samples were clearly negative. The PortaGHB test worked very well as a tool for the rapid screening of urine GHB positives and negatives in a professional setting. This study also shows that GHB abuse is infrequent or absent in an urban population. Although a previous report showed a high incidence of recreational GHB use among gay males (7), we could not corroborate this finding among the general San Francisco population, which included a higher incidence of gay men than in other U.S. cities. As GHB has a short half-life, it is possible that some GHB usage or abuse may have been cleared before urine testing was conducted. It is also possible that putative GHB abuse was not to the point where they needed medical care provided by the emergency department. Although this study revealed infrequent recreational use of GHB among drug of abuse cases in our population, there still remains a need for utilizing the simple-to-use rapid test for patients who are unconscious and/or exhibiting signs as potential date-rape victims.
